Cited by 103AI in cancer detectionRadiomics and Machine Learning in Medical ImagingCancer Immunotherapy and Biomarkers

Predicting tumour mutational burden from histopathological images using multiscale deep learning

Open access
Jain, Mika S., Massoud, Tarik F.·2020·Nature Machine Intelligence

Published version of a preprint

Integrity signals

Registry

Crossref · 10.1038/s42256-020-0190-5

Cites

Statistics

Recomputing p-values needs the paper’s full text.

Claims the paper makes

We couldn’t retrieve this paper’s full text, so its claims and self-check weren’t run. The registry and citation checks still apply.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

  • Numerous studies have demonstrated potential for AI to predict immunotherapy biomarkers from H&E images of NSCLC, including TMB, PD-L1 expression, and TILs.

    “Numerous studies have demonstrated the potential for using AI to predict immunotherapy biomarkers from H&E images of patients with NSCLC, including tumor mutation burden (TMB; ref. 76), PD-L1 expression (105), and TILs (106, 107).”

The citation lists haven’t been fetched yet

References 26 · Cited by 103

Authors
Jain, M. S., & Massoud, T. F.
Affiliations
Stanford University (US)
Corresponding author
  • Jain, Mika S.
  • Massoud, Tarik F.
Venue
Nature Machine Intelligence
Published
2020-06-15
Volume
2
Issue
6
Pages
356-362
ISSN
2522-5839 (ISSN-L)
OpenAlex
W3035105468
Cited by
103
References
26
Citations by year
2026: 9 · 2025: 15 · 2024: 21 · 2023: 22 · 2022: 24 · 2021: 12
FWCI
5.70
Type
journal article
Language
en
Open access
Locations
  • Nature Machine Intelligence (publishedVersion)
  • bioRxiv (Cold Spring Harbor Laboratory) (acceptedVersion)
Topics
  • Physical Sciences › Computer Science › Artificial Intelligence › AI in cancer detection
  • Health Sciences › Medicine › Radiology, Nuclear Medicine and Imaging › Radiomics and Machine Learning in Medical Imaging
  • Health Sciences › Medicine › Oncology › Cancer Immunotherapy and Biomarkers
Keywords
tumor mutational burden, histopathological images, lung adenocarcinoma, H&E staining, immunotherapy response biomarkers, genotype-phenotype correlation

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review